Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update.
Nigel S KeyAlok A KhoranaNicole M KudererKari BohlkeAgnes Y Y LeeJuan I ArcelusSandra L WongEdward P BalabanChristopher R FlowersLeigh E GatesAjay K KakkarMargaret A TemperoShilpi GuptaGary H LymanAnna FalangaPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Apixaban and rivaroxaban were added as options for extended pharmacologic thromboprophylaxis after cancer surgery, with a weak strength of recommendation. Apixaban was also added as an option for the treatment of VTE, with high quality of evidence and a strong recommendation.Additional information is available at www.asco.org/supportive-care-guidelines.